DNA Script is the world’s leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims at accelerating innovation in life sciences and technology through rapid, affordable, and high-quality DNA synthesis. DNA Script’s approach leverages nature's billions of years of evolution in synthesizing DNA to enable genome scale synthesis.
Location: France
Total raised: $311.17M
Investors 5
| Date | Name | Website |
| 16.07.2023 | M Ventures | m-ventures... |
| - | Idinvest P... | idinvest.c... |
| - | Agoranov | agoranov.c... |
| - | Illumina V... | illuminaVe... |
| - | Life Scien... | lspvc.com |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 11.12.2021 | Series C | $165M | - |
| 16.05.2019 | Series B | $38.5M | - |
| 04.04.2018 | - | $5.5M | - |
| 12.09.2017 | Series A | $13.17M | - |
| - | - | $89M | - |
Mentions in press and media 11
| Date | Title | Description |
| 18.03.2026 | DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia | Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours Establishes direct distribution networks across Latin America, Japan and South Korea Paris, France, 17 March 2026: DNA Script, a pioneer in DNA synthes... |
| 11.12.2021 | DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform | New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $280M |
| 17.05.2019 | DNA Script picks up $38.5 million to make DNA production faster and simpler | DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries from medicine to... |
| 17.05.2019 | Term Sheet — Friday, May 17 | AMAZON VS. UBER The food delivery wars are heating up in very interesting ways. Paid Content Securing the enterprise without boundaries From ExtraHop The funding news comes months after reports surfaced that Uber was in talks to acquire Del... |
| 16.05.2019 | Daily funding roundup - May 16th, 2019 | Core raises $4M; Retail Zipline secured $9.6M; Sawyer closed $11M; OpenFin landed $17M Core: Core is a meditation experience and personalized wellness company. Core has raised $4 million seed funding round led by Spero Ventures along with B... |
| 16.05.2019 | Paris-based biotech startup DNA Script raises €34.4 million in Series B funding to more efficiently synthesize DNA | DNA Script is a biotech company developing devices and methods to more quickly and affordably synthesize DNA using enzymes for research purposes, with potentially broad implications for the pharmaceutical, healthcare, and even agtech indust... |
| 16.05.2019 | DNA Script Secures $38.5M in Series B Funding | DNA Script, a Paris, France-based maker of de novo synthetic nucleic acids using an enzymatic technology, raised $38.5M in Series B funding. The round was led by LSP, with participation from Bpifrance, through its Large Venture fund and exi... |
| 04.04.2018 | DNA Script Receives $5.5M in Innovation Grants | DNA Script, a Paris, France-based developer of enzymatic DNA synthesis technology, received $5.5M in in non-dilutive financing. The European Commission (via Horizon 2020 European Innovation Council program) and Bpifrance (via the Aide au dé... |
| 13.09.2017 | Term Sheet — Wednesday, September 13 | CRYPTO DRAMA JAMIE DIMON VS. THE INTERNET: J.P. Morgan CEO Jamie Dimon lit the Internet on fire yesterday after his remarks about how Bitcoin is “a fraud” and how he would fire any employee trading bitcoin for being “stupid.” Paid Content W... |
| 12.09.2017 | DNA Script Raises €11M in Series A Financing | DNA Script, a Paris, France-based Synthetic DNA manufacturer, raised €11m ($13m) in Series A funding. The round was led by Illumina Ventures, with participation from Merck Ventures BV, the corporate venture arm of Merck KGaA, and existing i... |
Show more